In the news

PAG-backed AirPower Technologies Wins ESG Excellence Award

AirPower Technologies Limited, the leading independent industrial gases supplier in China and a PAG portfolio company, has won the 2023 HKVCA ESG Award of Excellence.

PAG Joins Steering Committee of ESG Data Convergence Initiative

PAG, a leading APAC-focused alternative investment firm, is delighted to share that the firm has been selected as a Steering Committee Member of the ESG Data Convergence Initiative (“EDCI”).

PAG Renewables Announces Landmark 30-Year Corporate PPA

30-year corporate PPA is the first of its kind in Japan

Interview: Asia Real Estate 'A Different World'

PAG Real Assets co-heads Broderick Storie and Phi Le explore the many differences between APAC's real estate markets and those in North America and Europe in an exclusive interview with PERE magazine.

PAG to Acquire Australian Venue Co from KKR

Global investment firm KKR and PAG, a leading alternative investment firm focused on Asia Pacific, today announced the signing of definitive agreements under which PAG will acquire KKR’s controlling interest in Australian Venue Co.

PAG Closes USD1.8 Billion PREP III Real Assets Fund

PREP III is the largest Asia Pacific-focused core-plus/value added office fund to close year-to-date

PAG Announces New Sustainability-Linked Subscription Line Credit Facility

Largest facility of its kind for a private credit fund in Asia-Pacific enables both enhanced investor returns and positive ESG impact

PAG and Mapletree Investments to Acquire Goldin Financial Global Centre

PAG, a leading investment firm focused on the Asia-Pacific region, and Mapletree Investments Pte Ltd (“Mapletree”), a global real estate development, investment, capital and property management company, announced today that they have entered into an agreement to form a 50/50 joint venture to acquire Hong Kong SAR ’s Goldin Financial Global Centre (“GFGC”) from the receivers for HKD5.6 billion (USD713 million).

PAG Portfolio Company BioRay Pharmaceutical Announces USD218 Million Strategic Financing Round

BioRay Pharmaceutical Co., Ltd., the leading autoimmune-focused biopharmaceutical firm in China, announces it has entered into final agreements for a strategic round of financing of over RMB1.5 billion (USD218 million) at a pre-money valuation of RMB13 billion (USD1.9 billion).

iQIYI Announces Closing of Private Placement of Convertible Notes to PAG

iQIYI, Inc. (Nasdaq: IQ) ("iQIYI" or the "Company"), a leading provider of online entertainment video services in China, today announced the closing of a private placement of US$500 million in secured convertible senior notes (the "Notes") to PAGAC IV-1 (Cayman) Limited, an affiliate of PAG, an investment firm focused on the Asia Pacific region (the "Investor").